<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04516863</url>
  </required_header>
  <id_info>
    <org_study_id>D-AMI 1.1</org_study_id>
    <nct_id>NCT04516863</nct_id>
  </id_info>
  <brief_title>A Validation Study of the German Autobiographical Memory Interview</brief_title>
  <official_title>Validation of the German Short Version of the Autobiographical Memory Interview in Patients With Depression and Healthy Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rheinhessen-Fachklinik Alzey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rheinhessen-Fachklinik Alzey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electroconvulsive therapy (ECT) is recommended for the treatment of severe depression. But,&#xD;
      despite the high remission rates the use of ECT is strongly limited by the social stigma and&#xD;
      treatment-emergent cognitive side effects in patients. The most relevant is retrograde&#xD;
      amnesia (RA), because it can persists for months and years. To measure RA after ECT the&#xD;
      short-form of the Autobiographical Memory Interview (SF-AMI) is commonly used. However, the&#xD;
      validation of the German SF-AMI has not yet been carried out. Thus, the aim of this study is&#xD;
      to validate the German SF-AMI in depressed patient and healthy controls.&#xD;
&#xD;
      The investigators hypothesize that the German SF-AMI is reliable and valid to quantify RA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To measure retrograde amnesia of autobiographical memory after ECT, various tests were used&#xD;
      so far. Currently, the short form of the Autobiographical Memory Interview (AMI-SF) was used&#xD;
      most frequently internationally. In Germany there is no validated translation of the AMI-SF.&#xD;
      However, in order to be able to systematically record the cognitive side effects of ECT in&#xD;
      clinical practice as well as in research in the German-speaking area, it is important to have&#xD;
      validated test procedures that can be successfully used in repeated measurements. In this&#xD;
      study, the German version of the AMI (D-AMI), i.e. the specificity of the German short&#xD;
      version of the autobiographical memory in patients with depression will be investigated. It&#xD;
      is also known in healthy people that autobiographical memory contents can no longer be called&#xD;
      up over time. Therefore, the aim of this study is to investigate whether a change in&#xD;
      autobiographical memory over the course of time in depressed patients differs from healthy&#xD;
      control subjects. It should also be shown whether this German short version for examining&#xD;
      autobiographical memory (D-AMI) can be carried out.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>German Autobiographical Memory Interview short-form</measure>
    <time_frame>pre-post (six weeks)</time_frame>
    <description>Changes in autobiographical memory measured with the German Autobiographical Memory Interview short-form pre-post in depressed patients vs. a healthy control Group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Rating Scale (HAMD-17)</measure>
    <time_frame>pre-post (six weeks)</time_frame>
    <description>Change in depression severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inventar Depressiver Symptome (IDS)</measure>
    <time_frame>pre-post (six weeks)</time_frame>
    <description>Change in depression severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>36-item Health Survey (SF-36)</measure>
    <time_frame>pre-post (six weeks)</time_frame>
    <description>Change in qualtiy of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Self-Evaluation-Memory (GSE-My)</measure>
    <time_frame>pre-post (six weeks)</time_frame>
    <description>Change in self-evaluation of memory</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Retrograde Amnesia</condition>
  <arm_group>
    <arm_group_label>Patients with depression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Major depression according to DSM-V and ICD-10 (ICD F32.1, F32.2, F32.3, F33.1, F33.2, F33.3)&#xD;
Hamilton Depression Rating Scale &gt; 17</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>- Mental health</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>German Autobiographical Memory Interview short-form</intervention_name>
    <description>Diagnostic Test</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>Patients with depression</arm_group_label>
    <other_name>D-AMI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  MDD&#xD;
&#xD;
          -  HDRS &gt; 17&#xD;
&#xD;
          -  Age 18-80&#xD;
&#xD;
          -  Ability to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Drugs or drug abuse or addictions&#xD;
&#xD;
          -  Use of benzodiazepine equivalent to lorazepam&gt; 1.5 mg per day&#xD;
&#xD;
          -  Cognitive impairments&#xD;
&#xD;
          -  History of traumatic brain injury&#xD;
&#xD;
          -  Relevant organic disease, e.g. Multiple sclerosis, Parkinson's disease&#xD;
&#xD;
          -  Bipolar illness, dementia or schizophrenic disorder&#xD;
&#xD;
          -  German is not the mother tongue&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah PD Dr. med. MSc. Kayser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rheinhessen-Fachklinik Alzey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah PD Dr. med. MSc. Kayser, MD</last_name>
    <phone>+ 49 6731 50 1278</phone>
    <email>s.kayser@rfk.landeskrankenhaus.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rheinhessen-Fachklinik Alzey</name>
      <address>
        <city>Alzey</city>
        <state>Rheinland-Pfalz</state>
        <zip>55232</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Kayser, MD</last_name>
      <phone>+49 6731 50 1278</phone>
      <email>s.kayser@rfk.landeskrankenhaus.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2020</study_first_posted>
  <last_update_submitted>August 17, 2020</last_update_submitted>
  <last_update_submitted_qc>August 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rheinhessen-Fachklinik Alzey</investigator_affiliation>
    <investigator_full_name>Sarah Kayser</investigator_full_name>
    <investigator_title>PD Dr. med. Sarah Kayser, MSc.</investigator_title>
  </responsible_party>
  <keyword>Electroconvulsive therapy</keyword>
  <keyword>Depression</keyword>
  <keyword>Cognitive side effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amnesia</mesh_term>
    <mesh_term>Amnesia, Retrograde</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

